Main competitors
P/E (N) Price to Book (N) PEG (N) EV / Sales (N) EV / EBITDA (N) EV / EBIT (N) Dividend Yield (N) Capi.($)
-8.34x3.89x-0.22x3.64x-6.72x-6.31x-.--% 2.08B
15.86x1.84x-2.3x3.43x9.24x10.12x0.64% 62.32B
26.63x4.01x1.99x5.4x15.8x19.68x0.59% 53.94B
32.01x6.45x0.62x10.82x20.41x24.16x-.--% 38.98B
-50.95x2.32x0.41x3.04x8.97x10.47x3.6% 37.89B
32.25x1.59x-1.09x3.47x10.65x12.39x-.--% 29.48B
-6.86x4.04x-0.36x9.58x-5.84x-5.53x-.--% 23.55B
15.64x3.08x4.63x2.8x8.65x8.53x-.--% 20.71B
47.29x4.78x0.25x5.15x35.69x32.98x-.--% 16.71B
24.9x3.48x0.02x5.15x13.89x19.33x-.--% 16.02B
-31.68x-5.5x0.75x14.78x-44.92x-46.7x-.--% 13.5B
-125.75x13127.65x2.71x12.83x-113.68x-124.9x-.--% 12.75B
64.13x26.15x0.6x38.99x55.14x56.87x0.15% 12.21B
15.87x - 0.17x3.42x12.52x15.01x-.--% 10.8B
44.54x - 3.5x - - - -.--% 10.12B
11.87x1.03x0.41x1.81x7.31x9.79x2.83% 6.28B
-42.1x - -0.76x - - - - 5.3B
-108.81x - 7.21x - - - -.--% 5.35B
57.48x4.06x-0.74x - - - - 5.46B
12.69x1.17x-0.19x2.12x5.57x6.66x1.77% 5.13B
Average 1.33x 824.38x 0.88x 7.90x 2.04x 2.66x 0.53% 19.43B
Weighted average by Cap. 7.85x 472.65x 0.47x 6.90x 7.04x 8.33x 0.63%
Biopharmaceuticals
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!